| For: | Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatr 2021; 11(7): 355-364 [PMID: 34327128 DOI: 10.5498/wjp.v11.i7.355] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i7/355.htm |
| Number | Citing Articles |
| 1 |
Zachary N. Mikkelson, Sharoderick C. Lowe, C. Noelle Patterson, Julia K. Whitehead, Erin E. Riley, Ella M. Dina, Julia M.E. Jarvholm, Kaya E. Hundley, Jason Martinez Leonides, Anna M. Fracchia, Anna Grace Crichton, Nicholas W. Simon. Sex-specific effects of the atypical antipsychotic risperidone on performance in a risky decision-making task. Behavioural Brain Research 2027; 516 doi: 10.1016/j.bbr.2026.116442
|
| 2 |
R. F. Nasyrova, A. V. Kidyaeva, V. V. Grechkina, N. A. Shnayder. Personalized approach to prediction and prevention of haloperidol-induced QT interval prolongation: brief review. Pharmacogenetics and Pharmacogenomics 2024; (1) doi: 10.37489/2588-0527-2024-1-20-30
|
| 3 |
Nicole Šafářová, Marián Kolenič, Ivana Tašková, Václav Čapek, Petra Fürstová, Filip Španiel. Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study. Frontiers in Psychiatry 2026; 17 doi: 10.3389/fpsyt.2026.1769162
|
| 4 |
Michelle L. Kielhold, David S. Jacobs, Alejandro Torrado Pacheco, Merridee J. Lefner, Alina P. Bogachuk, Joseph J. Lebowitz, Angela J. Langdon, John T. Williams, Larry S. Zweifel, Bita Moghaddam. Grin2a knockout in adolescent dopamine neurons disrupts prediction error signaling and produces a phenotype relevant to schizophrenia. Molecular Psychiatry 2026; 31(9) doi: 10.1038/s41380-026-03632-1
|
| 5 |
Jose O. Maximo, Joshua Richman, Adrienne C. Lahti. Trajectories of psychotic symptoms and fronto-parietal resting state functional connectivity MRI following an antipsychotic trial in medication-naïve first-episode psychosis patients. Neuropsychopharmacology 2026; doi: 10.1038/s41386-026-02515-x
|
| 6 |
Yasin Ali Muhammad. Reconceptualizing bipolar disorder through an integrative biological lens: synthesis, convergence, and emerging directions. Frontiers in Integrative Neuroscience 2026; 20 doi: 10.3389/fnint.2026.1775109
|
| 7 |
Cindy Bandala, Noemi Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, Valentín Martínez-López, Teresita Rocio Cruz-Hernández, Jazmín Carro-Rodríguez, Marco Antonio Vargas-Hernández, Iván Ignacio-Mejía, Alfonso Alfaro-Rodriguez, Eleazar Lara-Padilla. Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies. Pharmaceutics 2023; 15(2) doi: 10.3390/pharmaceutics15020693
|
| 8 |
Robert B. Zipursky, Neil Seeman, David S. Goldbloom. Mary V. Seeman: In Memoriam. The Canadian Journal of Psychiatry 2025; 70(3) doi: 10.1177/07067437241298375
|
| 9 |
Donald E․ Greydanus, Muhammad Waqar Azeem, Ahsan Nazeer. Schizophrenia and psychosis in children and adolescents: An inspiring journey of scientific progress and the rich influences of history and religion. Disease-a-Month 2025; 71(10) doi: 10.1016/j.disamonth.2025.101983
|
| 10 |
Kazusa Miyahara, Mizuki Hino, Risa Shishido, Ryuta Izumi, Atsuko Nagaoka, Hideki Hayashi, Akiyoshi Kakita, Hirooki Yabe, Hiroaki Tomita, Yasuto Kunii. Ethnicity-dependent effect of rs1799971 polymorphism on OPRM1 expression in the postmortem brain and responsiveness to antipsychotics. Journal of Psychiatric Research 2023; 166 doi: 10.1016/j.jpsychires.2023.08.007
|
| 11 |
Hae-Yeon Park, Moa Jung, Geun-Young Park, Jong In Lee, Youngkook Kim, Yeo Hyung Kim, Seong Hoon Lim, Yeun Jie Yoo, Sun Im. Investigating the link between antipsychotic use and post-stroke infections in older people: multi-centre propensity score analysis. Age and Ageing 2024; 53(6) doi: 10.1093/ageing/afae117
|
| 12 |
Roudabeh Vakil Monfared, Wedad Alhassen, Tri Minh Truong, Michael Angelo Maglalang Gonzales, Vincent Vachirakorntong, Siwei Chen, Pierre Baldi, Olivier Civelli, Amal Alachkar. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions. Cells 2021; 10(11) doi: 10.3390/cells10112967
|
| 13 |
Andrea-Lorena Garduño-Jiménez, Laura J. Carter. Insights into mode of action mediated responses following pharmaceutical uptake and accumulation in plants. Frontiers in Agronomy 2024; 5 doi: 10.3389/fagro.2023.1293555
|
| 14 |
Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, Anne E. Willems, Tessa L.L. Stout, Diederik E. Tenback. SwapIII: Clarifying the role of D2 receptor occupancy in psychosis and movement disorders. Psychiatry Research Communications 2026; 6(3) doi: 10.1016/j.psycom.2026.100266
|
| 15 |
Ghaith K. Mansour, Ahmad W. Hajjar, Adnan H. Hajjar, Abdullah Alissa, Hatouf H. Sukkarieh. Xanomeline–Trospium Validates Muscarinic Agonism as an Effective Non-Dopaminergic Treatment for Schizophrenia. International Journal of Molecular Sciences 2026; 27(13) doi: 10.3390/ijms27135734
|
| 16 |
Thomas Rajan, Roland Seifert. Analysis of clinical trials on drugs targeting dopamine receptors: a scoping review. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(3) doi: 10.1007/s00210-025-04710-x
|
| 17 |
Yujun Deng, Shouwei Wang, Lei Geng, Zhiwei Meng, Fangrong Chen, Xiaoxiao Yang, Feng Wang, Yuanli Chen, Zhiyu Li, Zhouling Xie. Evolving Strategies
for Previously Drugged Therapeutic
Targets: Medicinal Chemistry Insights from Paradigmatic Cases. Journal of Medicinal Chemistry 2026; 69(11) doi: 10.1021/acs.jmedchem.6c00858
|
| 18 |
Kazuyuki Fujihara. Beyond the γ-aminobutyric acid hypothesis of schizophrenia. Frontiers in Cellular Neuroscience 2023; 17 doi: 10.3389/fncel.2023.1161608
|
| 19 |
Harikrishnan Venkatesvaran, Sridharan Balu, Kuo-Wei Lan, Thomas C.-K. Yang. ZnO-NRs embedded guar-gum derived CS@HNTs: A bifunctional catalyst for electrochemical detection and photocatalytic applications. Journal of Environmental Chemical Engineering 2024; 12(1) doi: 10.1016/j.jece.2024.111895
|
| 20 |
José Antonio Monreal, Alexandre González-Rodríguez. Biological and Clinical Aspects on the Treatment of Schizophrenia and Related Disorders: New Challenges. Healthcare 2022; 10(9) doi: 10.3390/healthcare10091806
|
| 21 |
Olga Stȩpień-Wyrobiec, Marta Nowak, Grzegorz Wyrobiec, Emilia Morawiec, Magdalena Wierzbik-Strońska, Rafał Staszkiewicz, Beniamin Oskar Grabarek. Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: An update. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.1025414
|
| 22 |
Octavian Vasiliu, Beatrice Budeanu, Mihai-Ștefan Cătănescu. The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline–Trospium Combination: A Systematic Review. Pharmaceuticals 2024; 17(5) doi: 10.3390/ph17050610
|
| 23 |
Jürgen Wess, Antwi-Boasiako Oteng, Osvaldo Rivera-Gonzalez, Eugenia V. Gurevich, Vsevolod V. Gurevich. β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives. Pharmacological Reviews 2023; 75(5) doi: 10.1124/pharmrev.121.000302
|
| 24 |
Krittika Mittal, Adeline Arini, Niladri Basu. Screening 800 putative endocrine disrupting chemicals in a representative mammal, bird, and fish using a neurochemical cell-free testing platform. Chemosphere 2024; 362 doi: 10.1016/j.chemosphere.2024.142562
|
| 25 |
Béla Kiss, Balázs Krámos, István Laszlovszky. Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.785592
|
| 26 |
R. Sud, A. Banerjee, B. Viswanath, M. Purushottam, S. Jain. Non-synaptic mechanisms of antipsychotics may be key to their actions. Schizophrenia Research 2023; 261 doi: 10.1016/j.schres.2023.09.006
|
| 27 |
Arka Prava Roy, Arghya Chakravorty, Aarcha Appu Mini, Sudip Das, Mangaiyarkarasi Rajendiran, Vimala Raghavan. Emerging trends on nanomaterial-based simultaneous electrochemical sensing of dopamine and acetaminophen. Results in Chemistry 2024; 7 doi: 10.1016/j.rechem.2024.101489
|
| 28 |
Yunqing Zhu, Rui Yuan, Zhe Lu, Yuyanan Zhang, Zhewei Kang, Xiaoyang Feng, Guorui Zhao, Junyuan Sun, Jing Guo, Tong Yu, Yang Yang, Yaoyao Sun, Weihua Yue. Lipid-lowering and glucose-lowering drug targets differentially modulate antipsychotic treatment efficacy in schizophrenia. Cell Reports Medicine 2026; 7(3) doi: 10.1016/j.xcrm.2026.102653
|
| 29 |
Niels Hansen, Alina Isabel Rediske. The Locus Coeruleus Noradrenaline System in Delirium. Frontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.784356
|
| 30 |
Ciaran Browne, Anurag Nasa, Linda Kelly, Sahar Riaz, Vitallia Sooknarine, Michael O’Connor, Orla Mitchell, Emma O’Hora, An Hsu, Ahmad Almulla, Areej Gazzaz, Conan Brady, Colm Healy, Erik O’Hanlon, Michael Connaughton, Mary Cannon, Darren William Roddy. Pulvinar and Ventral Thalamic Nuclei Changes Occur Early Along the Psychosis Spectrum. Schizophrenia Bulletin Open 2025; 6(1) doi: 10.1093/schizbullopen/sgaf016
|
| 31 |
Brandon S. Pruett, Calley Johnston, Bradley G. Burk. Handbook of Practical Psychopharmacology. 2024; doi: 10.1176/appi.books.9798894551913.lg06
|
| 32 |
Shiva Shanker Reddy Mukku, Ravi Kumar Nadella, Sumanth Ediga Kornapalli. Cariprazine for late-life psychiatric illness. Journal of Geriatric Mental Health 2021; 8(2) doi: 10.4103/jgmh.jgmh_43_21
|
| 33 |
Brayden Kameg, Josh Palmer, Tanner Herb. Cobenfy™ for the Treatment of Schizophrenia: A Clinical Overview. Journal of Psychosocial Nursing and Mental Health Services 2025; 63(9) doi: 10.3928/02793695-20250811-02
|
| 34 |
Yuriko Iwakura, Ryoka Kawahara-Miki, Satoshi Kida, Hidekazu Sotoyama, Ramil Gabdulkhaev, Hitoshi Takahashi, Yasuto Kunii, Mizuki Hino, Atsuko Nagaoka, Ryuta Izumi, Risa Shishido, Toshiyuki Someya, Hirooki Yabe, Akiyoshi Kakita, Hiroyuki Nawa. Elevation of EGR1/zif268, a Neural Activity Marker, in the Auditory Cortex of Patients with Schizophrenia and its Animal Model. Neurochemical Research 2022; 47(9) doi: 10.1007/s11064-022-03599-9
|
| 35 |
Indu Singh, Haritima Singh, Divakar Sharma, Anushri Keshri, Naveen Gaurav, Megh Singh Dhakad, Mirza Masroor Ali Beg. Psychotropic Drugs: A Promising Non‐Antibiotic Agent to Combat Multi‐Drug‐Resistant Microorganisms. Drug Development Research 2026; 87(6) doi: 10.1002/ddr.70380
|
| 36 |
Adan Baumel, Assif Yitzhaky, Libi Hertzberg. GRIA Gene Expression in Schizophrenia: A Participant-Level Meta-Analysis. Alpha Psychiatry 2026; 27(3) doi: 10.31083/AP46200
|
| 37 |
Maria Rosaria Melis, Fabrizio Sanna, Antonio Argiolas. Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review. Brain Sciences 2022; 12(7) doi: 10.3390/brainsci12070826
|
| 38 |
Madhusmita Rout, Sumit Sharma, Nishant Thakur, Samrat Chauhan, Sanchit Dhankhar. Design and Characterization of Niosomal In-Situ Gel for Enhanced Bioavailability of Chlorpromazine HCl in Schizophrenia. Current Drug Therapy 2026; 21(6) doi: 10.2174/0115748855396615251031210933
|
| 39 |
Heidi N. Boyda, Michelle Pham, Joyce Huang, Amanzo A. Ho, Ric M. Procyshyn, Jessica W. Y Yuen, William G. Honer, Alasdair M. Barr. Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.765905
|
| 40 |
Haley Maria Dourron, Camilla Strauss, Peter S. Hendricks. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Pharmacological Reviews 2022; 74(4) doi: 10.1124/pharmrev.121.000514
|
| 41 |
Chitra Vinnakota, Matthew R. Hudson, Nigel C. Jones, Suresh Sundram, Rachel A. Hill. Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411835
|
| 42 |
Ignasi Oliveras, Toni Cañete, Daniel Sampedro-Viana, Cristóbal Río-Álamos, Adolf Tobeña, Maria Giuseppa Corda, Osvaldo Giorgi, Alberto Fernández-Teruel. Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia-
related Symptoms. Current Neuropharmacology 2023; 21(9) doi: 10.2174/1570159X21666230221093644
|
| 43 |
Alicia Rosell-Hidalgo, Julie Eakins, Paul Walker, Anthony L. Moore, Taravat Ghafourian. Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays. Biomedicines 2023; 11(12) doi: 10.3390/biomedicines11123272
|
| 44 |
Maya Tamara Mawardani, Rifky Saldi A. Wahid. Gambaran Kadar Ureum Terhadap Konsumsi Haloperidol dan/atau Chlorpromazine Dengan Obat Antipsikotik Atipikal Pada Pasien Skizofrenia. JSN : Jurnal Sains Natural 2023; 1(3) doi: 10.35746/jsn.v1i3.389
|
| 45 |
Sriparno Patra, Soumitra Ghosh, Rupa Gohain. A Case Report of Armodafinil Abuse in Chronic Schizophrenia. Indian Journal of Private Psychiatry 2025; 19(2) doi: 10.5005/jp-journals-10067-0194
|
| 46 |
Jeremy Mills. More than a Half-Century with Haloperidol: Glories, Disparities, and Use Today. Issues in Mental Health Nursing 2023; 44(1) doi: 10.1080/01612840.2022.2158683
|
| 47 |
Toshiaki Onitsuka, Yoji Hirano, Takanobu Nakazawa, Kayo Ichihashi, Kenichiro Miura, Ken Inada, Ryo Mitoma, Norio Yasui‐Furukori, Ryota Hashimoto. Toward recovery in schizophrenia: Current concepts, findings, and future research directions. Psychiatry and Clinical Neurosciences 2022; 76(7) doi: 10.1111/pcn.13342
|
| 48 |
C. Corey Hardin, Eelco F.M. Wijdicks, Allan H. Ropper. Neuroleptic Malignant Syndrome. New England Journal of Medicine 2024; 391(12) doi: 10.1056/NEJMra2404606
|
| 49 |
Claudia Mehler-Wex, Timo D. Vloet, Manfred Gerlach. Neuro-/Psychopharmaka im Kindes- und Jugendalter. 2023; doi: 10.1007/978-3-662-65267-1_6
|
| 50 |
Adam R. Wronski, Bryan W. Brooks. Global occurrence and aquatic hazards of antipsychotics in sewage influents, effluent discharges and surface waters. Environmental Pollution 2023; 320 doi: 10.1016/j.envpol.2023.121042
|
| 51 |
Mulualem Kelebie, Getasew Kibralew, Gebresilassie Tadesse, Girum Nakie, Dawed Ali, Biruk Fanta, Mulu Muche, Setegn Fentahun, Gidey Rtbey, Girmaw Medfu Takelle. Prevalence and predictors of metabolic syndrome among psychiatric patients receiving antipsychotic treatment in Africa: a systematic review and meta-analysis. BMC Psychiatry 2025; 25(1) doi: 10.1186/s12888-025-06894-1
|
| 52 |
Zhen Zhao, Xin Li, Yingying Xie, Liyuan Lin, Luli Wei, Zhongyu Chang, Yun Luo, Haoyang Dong, Xue Zhang, Qiqi Dong, Chunshui Yu, Meng Liang, Hao Ding, Wen Qin. Resolving the heterogeneity of dopamine subsystems dysfunction in schizophrenia: a PET meta-analysis. Schizophrenia 2025; 11(1) doi: 10.1038/s41537-025-00684-0
|
| 53 |
Nathalie V. Kirby, Emily J. Tetzlaff, Sean A. Kidd, Eric E. Brown, Mariya Bezgrebelna, Liv Yoon, Sarah B. Henderson, Glen P. Kenny. Susceptibility of persons with schizophrenia to extreme heat: A critical review of physiological, behavioural, and social factors. Science of The Total Environment 2025; 995 doi: 10.1016/j.scitotenv.2025.179965
|